PHILIPS Sleep and Respiratory Care has announced a new partnership with digital medication management and pharmacy engagement platform MedAdvisor, designed to transform how patients access sleep health support.
Through MedAdvisor's pharmacy- and patient-facing platforms, the partnership will help identify patients that may be at risk of obstructive sleep apnoea (OSA) based on medications dispensed.
Research shows that many people with OSA take medication for hypertension, heart disease, type 2 diabetes and obesity, and the partnership will see patients taking these medicines prompted to complete an OSA screening quiz (PD 24 Apr).
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Nov 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Nov 25
